{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:28:17Z","timestamp":1787840897530,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Morphoea is a sclerosing disorder of skin and subcutaneous tissue. Paediatric morphoea shows increased prevalence of various auto-immune diseases, bone deformities, and systemic abnormalities. There is paucity of studies on various immunological, skeletal, and thyroid function abnormalities in paediatric morphoea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>To describe immunological, skeletal, and thyroid function abnormalities present in paediatric morphoea patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study was conducted from January 2021 to March 2023 in the Dermatology outpatient department in a tertiary care hospital. All paediatric morphoea patients were included in this study. All were subjected to detailed history, clinical examination, and investigations including complete blood count, serum IgE, anti-nuclear antibody, thyroid function tests, anti-thyroid peroxidase antibodies, and radiological investigations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 42 children were recruited, out of which 61.90% were females and 38.09% were males. The majority were in the age group of 4\u20138 years. The most common type of morphoea was encoup de sabre. Anaemia was present in 14.28% patients. Serum IgE levels were raised in 33.33% patients. Thyroid stimulating hormone was raised in 11.9% patients. 33.33% had raised anti-thyroid peroxidase levels. Anti-nuclear antibody titres and rheumatoid factor were raised in 7.14% and 4.76% patients, respectively. Magnetic resonance imaging brain revealed abnormalities in three patients as hyper-intensities in subcortical white matter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Morphoea in children can be associated with varied immunological, osteoarticular, and neurological abnormalities. This study highlights the multi-system involvement in morphoea and the need for larger data and well-designed therapeutic trials for generating evidence-based treatment of this potentially disfiguring disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_1081_23","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T07:01:10Z","timestamp":1731913270000},"page":"50-50","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Immunological, Skeletal, and Thyroid Function Abnormalities in Paediatric Morphoea"],"prefix":"10.4103","volume":"70","author":[{"given":"Vibhu","family":"Mendiratta","sequence":"first","affiliation":[{"name":"From the Department of Dermatology and STD, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Dermatology and STD, SLBSGMCH, Mandi, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Meena","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and STD, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvarna","family":"Samudrala","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and STD, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Parmar","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology and STD, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"R1-20250331","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea:Part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250331","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0378-6323.93628","article-title":"Morphea:Evidence-based recommendations for treatment","volume":"78","author":"Fett","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R3-20250331","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma):Review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R4-20250331","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"R5-20250331","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","article-title":"Scleroderma in children and adolescents","volume":"28","author":"Murray","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"R6-20250331","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma:Clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R7-20250331","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.12758","article-title":"Risk factors for morphoea disease severity:A retrospective review of 114 paediatric patients","volume":"170","author":"Pequet","year":"2014","journal-title":"Br J Dermatol"},{"key":"R8-20250331","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.autrev.2018.02.004","article-title":"Disease course and long-term outcome of juvenile localized scleroderma:Experience from a single pediatric rheumatology Centre and literature review","volume":"17","author":"Martini","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R9-20250331","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/ced.14234","article-title":"Paediatric morphoea:A holistic review. Part 1:Epidemiology, aetiopathogenesis and clinical classification","volume":"45","author":"Kaushik","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"R10-20250331","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaad.2012.04.003","article-title":"Coexistence of lichen sclerosus and morphea:A retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center","volume":"67","author":"Kreuter","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R11-20250331","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/2397198320925684","article-title":"Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre","volume":"6","author":"Saracino","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"key":"R12-20250331","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"Chung","year":"2006","journal-title":"Clin Dermatol"},{"key":"R13-20250331","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localised scleroderma:A multi-centre study","volume":"91","author":"Zannin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R14-20250331","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0190-9622(87)70251-5","article-title":"Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis","volume":"17","author":"Falanga","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R15-20250331","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaad.2018.03.005","article-title":"Inflammatory arthritis in pediatric patients with morphea","volume":"79","author":"Kashem","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R16-20250331","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.1989.tb01350.x","article-title":"An investigation into the incidence of auto-immune disorders in patients with localized morphoea","volume":"120","author":"Harrington","year":"1989","journal-title":"Br J Dermatol"},{"key":"R17-20250331","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphoea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol"},{"key":"R18-20250331","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.144230","article-title":"Thyroid dysfunctions in morphoea:A preliminary report","volume":"80","author":"Hassan","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R19-20250331","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5114\/ada.2018.75839","article-title":"Morphea and antithyroid antibodies","volume":"35","author":"Da\u0144czak-Pazdrowska","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"R20-20250331","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3389\/fimmu.2019.01487","article-title":"Autoantibodies in morphea:An update","volume":"10","author":"Khatri","year":"2019","journal-title":"Front Immunol"},{"key":"R21-20250331","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R22-20250331","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/idoj.IDOJ_284_19","article-title":"Update on management of morphea (localized scleroderma) in children","volume":"11","author":"George","year":"2020","journal-title":"Indian Dermatol Online J"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1081_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:30:33Z","timestamp":1787837433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1081_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_1081_23","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"2023-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}